SEC Info - Biomerica Inc. - ‘10-Q’ for 2/28/21

SEC Info℠

Home

Help

Please Sign In

Biomerica Inc. – ‘10-Q’ for 2/28/21 – ‘EX-101.SCH’

On: Wednesday, 4/14/21, at 4:39pm ET · For: 2/28/21 · Accession #: 1513162-21-56 · File #: 1-37863

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/14/21  Biomerica Inc.                    10-Q        2/28/21   42:3.3M                                   Zacks Inv Resear… Inc/FA

Quarterly Report — Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report -- form10q                         HTML    334K 
 8: EX-31.1     Certification -- §302 - SOA'02 -- exhibit31_1       HTML     17K 
 9: EX-31.2     Certification -- §302 - SOA'02 -- exhibit31_2       HTML     17K 
10: EX-32.1     Certification -- §906 - SOA'02 -- exhibit32_1       HTML     14K 
11: EX-32.2     Certification -- §906 - SOA'02 -- exhibit32_2       HTML     14K 
12: R1          Document And Entity Information                     HTML     42K 
13: R2          Condensed Consolidated Statements of Operations     HTML    108K 
                and Comprehensive Loss (Unaudited)                               
14: R3          Condensed Consolidated Balance Sheets               HTML    116K 
15: R4          Condensed Consolidated Balance Sheets               HTML     48K 
                (Parentheticals)                                                 
16: R5          Condensed Consolidated Statements of Shareholders'  HTML     67K 
                Equity (Unaudited)                                               
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    101K 
                (Unaudited)                                                      
18: R7          Basis of Presentation                               HTML     18K 
19: R8          Significant Accounting Policies                     HTML     98K 
20: R9          Shareholders' Equity                                HTML     22K 
21: R10         Geographic Information                              HTML     53K 
22: R11         Leases                                              HTML     37K 
23: R12         Commitments and Contingencies                       HTML     22K 
24: R13         Subsequent Events                                   HTML     17K 
25: R14         Accounting Policies, by Policy (Policies)           HTML    147K 
26: R15         Significant Accounting Policies (Tables)            HTML     76K 
27: R16         Geographic Information (Tables)                     HTML     52K 
28: R17         Leases (Tables)                                     HTML     36K 
29: R18         Significant Accounting Policies (Details)           HTML     99K 
30: R19         Significant Accounting Policies (Details) -         HTML     23K 
                Inventories                                                      
31: R20         Significant Accounting Policies (Details) -         HTML     34K 
                Options Activity                                                 
32: R21         Significant Accounting Policies (Details) -         HTML     31K 
                Revenue from contracts with customers                            
33: R22         Shareholders' Equity (Details)                      HTML     35K 
34: R23         Geographic Information (Details)                    HTML     20K 
35: R24         Geographic Information (Details) - Financial        HTML     37K 
                information about foreign and domestic operations                
                and export sales                                                 
36: R25         Leases (Details)                                    HTML     31K 
37: R26         Leases (Details) - Supplemental cash flow           HTML     23K 
                information related to leases                                    
38: R27         Leases (Details) - The maturity of lease            HTML     29K 
                liabilities                                                      
39: R28         Commitments and Contingencies (Details)             HTML     26K 
41: XML         IDEA XML File -- Filing Summary                      XML     68K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX     52K 
 2: EX-101.INS  XBRL Instance -- bmra-20210228                       XML    750K 
 4: EX-101.CAL  XBRL Calculations -- bmra-20210228_cal               XML     91K 
 5: EX-101.DEF  XBRL Definitions -- bmra-20210228_def                XML    434K 
 6: EX-101.LAB  XBRL Labels -- bmra-20210228_lab                     XML    701K 
 7: EX-101.PRE  XBRL Presentations -- bmra-20210228_pre              XML    424K 
 3: EX-101.SCH  XBRL Schema -- bmra-20210228                         XSD     89K 
42: ZIP         XBRL Zipped Folder -- 0001513162-21-000056-xbrl      Zip     93K

‘EX-101.SCH’ — XBRL Schema — bmra-20210228

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xs:schema xmlns:bmra="http://www.biomerica.com/20210228" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://www.biomerica.com/20210228" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">

<xs:annotation>

<xs:appinfo>

<link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210228_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>

<link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210228_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>

<link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210228_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>

<link:linkbaseRef xlink:type="simple" xlink:href="bmra-20210228_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>

<link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatement" id="bmra_r_ConsolidatedIncomeStatement">

<link:definition> 001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedIncomeStatementAlt0" id="bmra_r_ConsolidatedIncomeStatementAlt0">

<link:definition> 001 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) Alternate 0 </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet" id="bmra_r_ConsolidatedBalanceSheet">

<link:definition> 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedBalanceSheet_Parentheticals" id="bmra_r_ConsolidatedBalanceSheet_Parentheticals">

<link:definition> 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ShareholdersEquityType2or3" id="bmra_r_ShareholdersEquityType2or3">

<link:definition> 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ConsolidatedCashFlow" id="bmra_r_ConsolidatedCashFlow">

<link:definition> 005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/BASISOFPRESENTATION" id="bmra_r_BASISOFPRESENTATION">

<link:definition> 006 - Disclosure - BASIS OF PRESENTATION </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIES" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIES">

<link:definition> 007 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITY" id="bmra_r_SHAREHOLDERSEQUITY">

<link:definition> 008 - Disclosure - SHAREHOLDERS' EQUITY </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATION" id="bmra_r_GEOGRAPHICINFORMATION">

<link:definition> 009 - Disclosure - GEOGRAPHIC INFORMATION </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/LEASES" id="bmra_r_LEASES">

<link:definition> 010 - Disclosure - LEASES </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIES" id="bmra_r_COMMITMENTSANDCONTINGENCIES">

<link:definition> 011 - Disclosure - COMMITMENTS AND CONTINGENCIES </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SUBSEQUENTEVENTS" id="bmra_r_SUBSEQUENTEVENTS">

<link:definition> 012 - Disclosure - SUBSEQUENT EVENTS </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/AccountingPoliciesByPolicy" id="bmra_r_AccountingPoliciesByPolicy">

<link:definition> 013 - Disclosure - Accounting Policies, by Policy (Policies) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESTables" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESTables">

<link:definition> 014 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONTables" id="bmra_r_GEOGRAPHICINFORMATIONTables">

<link:definition> 015 - Disclosure - GEOGRAPHIC INFORMATION (Tables) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/LEASESTables" id="bmra_r_LEASESTables">

<link:definition> 016 - Disclosure - LEASES (Tables) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SIGNIFICANTACCOUNTINGPOLICIESDetails" id="bmra_r_SIGNIFICANTACCOUNTINGPOLICIESDetails">

<link:definition> 017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/InventoriesTable" id="bmra_r_InventoriesTable">

<link:definition> 018 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Inventories </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/OptionsActivityTable" id="bmra_r_OptionsActivityTable">

<link:definition> 019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Options Activity </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/RevenuefromcontractswithcustomersTable" id="bmra_r_RevenuefromcontractswithcustomersTable">

<link:definition> 020 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details) - Revenue from contracts with customers </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SHAREHOLDERSEQUITYDetails" id="bmra_r_SHAREHOLDERSEQUITYDetails">

<link:definition> 021 - Disclosure - SHAREHOLDERS' EQUITY (Details) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/GEOGRAPHICINFORMATIONDetails" id="bmra_r_GEOGRAPHICINFORMATIONDetails">

<link:definition> 022 - Disclosure - GEOGRAPHIC INFORMATION (Details) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/FinancialinformationaboutforeignanddomesticoperationsandexportsalesTable" id="bmra_r_FinancialinformationaboutforeignanddomesticoperationsandexportsalesTable">

<link:definition> 023 - Disclosure - GEOGRAPHIC INFORMATION (Details) - Financial information about foreign and domestic operations and export sales </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/LEASESDetails" id="bmra_r_LEASESDetails">

<link:definition> 024 - Disclosure - LEASES (Details) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/SupplementalcashflowinformationrelatedtoleasesTable" id="bmra_r_SupplementalcashflowinformationrelatedtoleasesTable">

<link:definition> 025 - Disclosure - LEASES (Details) - Supplemental cash flow information related to leases </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/ThematurityofleaseliabilitiesTable" id="bmra_r_ThematurityofleaseliabilitiesTable">

<link:definition> 026 - Disclosure - LEASES (Details) - The maturity of lease liabilities </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/COMMITMENTSANDCONTINGENCIESDetails" id="bmra_r_COMMITMENTSANDCONTINGENCIESDetails">

<link:definition> 027 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://www.biomerica.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">

<link:definition> 000 - Document - Document And Entity Information </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

</link:roleType>

</xs:appinfo>

</xs:annotation>

<xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>

<xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>

<xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>

<xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>

<xs:element name="InventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_InventoriesAbstract"/>

<xs:element name="OptionsActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OptionsActivityAbstract"/>

<xs:element name="RevenueFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenueFromContractsWithCustomersAbstract"/>

<xs:element name="GeographicInformationDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureAbstract"/>

<xs:element name="FinancialInformationAboutForeignAndDomesticOperationsAndExportSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_FinancialInformationAboutForeignAndDomesticOperationsAndExportSalesAbstract"/>

<xs:element name="SupplementalCashFlowInformationRelatedToLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalCashFlowInformationRelatedToLeasesAbstract"/>

<xs:element name="TheMaturityOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TheMaturityOfLeaseLiabilitiesAbstract"/>

<xs:element name="SupplementalDisclosureOfCashFlowInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SupplementalDisclosureOfCashFlowInformationAbstract"/>

<xs:element name="CashPaidDuringThePeriodForAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_CashPaidDuringThePeriodForAbstract"/>

<xs:element name="RevenuesFromSalesToUnaffiliatedCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RevenuesFromSalesToUnaffiliatedCustomersAbstract"/>

<xs:element name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>

<xs:element name="PreferredStockUndesignatedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="bmra_PreferredStockUndesignatedShares"/>

<xs:element name="StockIssuedDuringPeriodValuePreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_StockIssuedDuringPeriodValuePreferredStock"/>

<xs:element name="StockIssuedDuringPeriodSharesPreferredStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_StockIssuedDuringPeriodSharesPreferredStock"/>

<xs:element name="IncreaseDecreaseInDeferredRentLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_IncreaseDecreaseInDeferredRentLiability"/>

<xs:element name="OperatingLeaseRightofUseAssetAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseRightofUseAssetAmortization"/>

<xs:element name="IncreaseDecreaseInLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_IncreaseDecreaseInLeaseLiability"/>

<xs:element name="ProceedsFromEquityFinancingOfficer" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_ProceedsFromEquityFinancingOfficer"/>

<xs:element name="EstablishmentOfRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_EstablishmentOfRightOfUseAsset"/>

<xs:element name="EstablishmentOfLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_EstablishmentOfLeaseLiability"/>

<xs:element name="GeographicInformationDisclosureTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GeographicInformationDisclosureTextBlock"/>

<xs:element name="PrepaidsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PrepaidsPolicyPolicyTextBlock"/>

<xs:element name="ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ScheduleOfCashFlowSupplementalDisclosuresRelatedToLeaseTableTextBlock"/>

<xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityTable"/>

<xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsOptionsActivityLineItems"/>

<xs:element name="GEOGRAPHICINFORMATIONDetailsFinancialinformationaboutforeignanddomesticoperationsandexportsalesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsFinancialinformationaboutforeignanddomesticoperationsandexportsalesTable"/>

<xs:element name="GEOGRAPHICINFORMATIONDetailsFinancialinformationaboutforeignanddomesticoperationsandexportsalesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsFinancialinformationaboutforeignanddomesticoperationsandexportsalesLineItems"/>

<xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsTable"/>

<xs:element name="SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SIGNIFICANTACCOUNTINGPOLICIESDetailsLineItems"/>

<xs:element name="SHAREHOLDERSEQUITYDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_SHAREHOLDERSEQUITYDetailsTable"/>

<xs:element name="SHAREHOLDERSEQUITYDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SHAREHOLDERSEQUITYDetailsLineItems"/>

<xs:element name="PublicTradingVolumeOfStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="bmra_PublicTradingVolumeOfStock"/>

<xs:element name="GEOGRAPHICINFORMATIONDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_GEOGRAPHICINFORMATIONDetailsTable"/>

<xs:element name="GEOGRAPHICINFORMATIONDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_GEOGRAPHICINFORMATIONDetailsLineItems"/>

<xs:element name="PropertySubjectToOrAvailableForOperatingLease_Domain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PropertySubjectToOrAvailableForOperatingLease_Domain"/>

<xs:element name="LeaseAmendmentDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LeaseAmendmentDomain"/>

<xs:element name="LEASESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_LEASESDetailsTable"/>

<xs:element name="LEASESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LEASESDetailsLineItems"/>

<xs:element name="OperatingLeaseInitiationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OperatingLeaseInitiationDate"/>

<xs:element name="COMMITMENTSANDCONTINGENCIESDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="bmra_COMMITMENTSANDCONTINGENCIESDetailsTable"/>

<xs:element name="COMMITMENTSANDCONTINGENCIESDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_COMMITMENTSANDCONTINGENCIESDetailsLineItems"/>

<xs:element name="RoyaltyPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_RoyaltyPercentage"/>

<xs:element name="ClinicalTrialAgreementMaximumBudgetedCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="bmra_ClinicalTrialAgreementMaximumBudgetedCosts"/>

<xs:element name="LeaseAmendmentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="bmra_LeaseAmendmentAxis"/>

<xs:element name="A5PercentConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_A5PercentConvertiblePreferredStockMember"/>

<xs:element name="AtTheMarketMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_AtTheMarketMember"/>

<xs:element name="BuildingInIrvineCaliforniaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_BuildingInIrvineCaliforniaMember"/>

<xs:element name="ClinicalLabMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ClinicalLabMember"/>

<xs:element name="ContractManufacturingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_ContractManufacturingMember"/>

<xs:element name="FirstAmendmentToLeaseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_FirstAmendmentToLeaseMember"/>

<xs:element name="LabSuppliesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_LabSuppliesMember"/>

<xs:element name="OTCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OTCMember"/>

<xs:element name="OtherMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_OtherMember"/>

<xs:element name="PhysiciansOfficeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PhysiciansOfficeMember"/>

<xs:element name="PurchasedTechnologyRightsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_PurchasedTechnologyRightsMember"/>

<xs:element name="SubscriptionsReceivableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_SubscriptionsReceivableMember"/>

<xs:element name="TelconAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_TelconAgreementMember"/>

<xs:element name="UniversityOfTexasHealthScienceCenterMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_UniversityOfTexasHealthScienceCenterMember"/>

<xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="bmra_DocumentAndEntityInformationAbstract"/>

</xs:schema>

↑Top

Filing Submission 0001513162-21-000056 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Biomerica Inc. – ‘10-Q’ for 2/28/21 – ‘EX-101.SCH’

On: Wednesday, 4/14/21, at 4:39pm ET · For: 2/28/21 · Accession #: 1513162-21-56 · File #: 1-37863

Previous ‘10-Q’: ‘10-Q’ on 1/14/21 for 11/30/20 · Next: ‘10-Q’ on 10/14/21 for 8/31/21 · Latest: ‘10-Q’ on 4/12/24 for 2/29/24

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.SCH’ — XBRL Schema — bmra-20210228

This Exhibit is an XBRL XML File.

Quarterly Report — Form 10-Q
Filing Table of Contents